Outsourcing-pharma16h
Women in STEM: Gitte Barknowitz’s journey to leading global initiatives
From exploring the wonders of plants as a curious teen to leading global initiatives at SCIEX, Gitte Barknowitz has carved ...
Outsourcing-pharma4d
AstraZeneca licenses CSPC’s cardiovascular drug in $2 billion deal
The big pharma company AstraZeneca has forged a licensing pact worth $2 billion with the Chinese firm CSPC Pharmaceutical ...
Outsourcing-pharma4d
Antag Therapeutics gets FDA clearance to start clinical trials with new obesity drug
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
Outsourcing-pharma6d
Preparing for the US Biosecure Act - what does it mean for the pharma industry?
The current status of the Biosecure Act is that it was passed ​ by the US House of Representatives on Sep 9, with a vote of ...
Outsourcing-pharma6d
Small molecules in focus as Recipharm bolsters global production facilities
Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm ...
Outsourcing-pharma3d
Jane Koo on leading regulatory affairs at CTMC: A journey from mAbs to cellular therapies
Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...
Outsourcing-pharma4d
Evaxion’s AI-immunology platform shines in multiple clinical trials
Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...
Outsourcing-pharma6d
Drug discovery and bringing new medicine to market - the future of AI in pharma
Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a value of $22.6 billion dollars by next year (2025). One area it is thriving ...